07 Sep 2016 --- Nestlé’s Institute of Health Science is set to acquire Phagenesis, a UK based company developing an innovative pharyngeal electrical stimulation device used to treat dysphagia. Also known as swallowing difficulty, the condition is commonly experienced by post stroke patients, but also the elderly and those undergoing post mechanical ventilation in intensive care units.
